Literature DB >> 7953942

Sodium cromoglycate (Intal) as an anti-inflammatory agent for the treatment of chronic asthma.

A M Edwards1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7953942     DOI： 10.1111/j.1365-2222.1994.tb00964.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN： 0954-7894            Impact factor:   5.018


× No keyword cloud information.
  5 in total

Review 1.  Management of asthma in adults: current therapy and future directions.

Authors:  R H Green; C E Brightling; I D Pavord; A J Wardlaw
Journal:  Postgrad Med J       Date:  2003-05       Impact factor: 2.401

2.  Oral delivery of sodium cromolyn: preliminary studies in vivo and in vitro.

Authors:  A Leone-Bay; H Leipold; D Sarubbi; B Variano; T Rivera; R A Baughman
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

Review 3.  Inhaled disodium cromoglycate (DSCG) as maintenance therapy in children with asthma: a systematic review.

Authors:  M J Tasche; J H Uijen; R M Bernsen; J C de Jongste; J C van der Wouden
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

4.  Inhibition of tumour necrosis factor-alpha (TNF-alpha) release from mast cells by the anti-inflammatory drugs, sodium cromoglycate and nedocromil sodium.

Authors:  E Y Bissonnette; J A Enciso; A D Befus
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

Review 5.  Can FDA-Approved Immunomodulatory Drugs be Repurposed/Repositioned to Alleviate Chronic Pain?

Authors:  Kufreobong E Inyang; Joseph K Folger; Geoffroy Laumet
Journal:  J Neuroimmune Pharmacol       Date:  2021-05-26       Impact factor: 4.147
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.